Accendra Health (ACH) EBIT (2016 - 2025)
Historic EBIT for Accendra Health (ACH) over the last 17 years, with Q3 2025 value amounting to $26.5 million.
- Accendra Health's EBIT fell 1482.99% to $26.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$275.9 million, marking a year-over-year decrease of 33433.46%. This contributed to the annual value of -$207.8 million for FY2024, which is 29880.68% down from last year.
- Latest data reveals that Accendra Health reported EBIT of $26.5 million as of Q3 2025, which was down 1482.99% from -$39.7 million recorded in Q2 2025.
- In the past 5 years, Accendra Health's EBIT ranged from a high of $146.7 million in Q1 2021 and a low of -$262.7 million during Q4 2024
- Moreover, its 5-year median value for EBIT was $26.5 million (2025), whereas its average is $20.9 million.
- In the last 5 years, Accendra Health's EBIT skyrocketed by 126381.55% in 2021 and then plummeted by 53774.35% in 2024.
- Quarter analysis of 5 years shows Accendra Health's EBIT stood at $62.0 million in 2021, then plummeted by 186.23% to -$53.5 million in 2022, then surged by 212.23% to $60.0 million in 2023, then plummeted by 537.74% to -$262.7 million in 2024, then soared by 110.07% to $26.5 million in 2025.
- Its EBIT stands at $26.5 million for Q3 2025, versus -$39.7 million for Q2 2025 and $124000.0 for Q1 2025.